Research Article
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
Table 2
Univariate and multivariate analyses of C2 expression for overall survival in HCC patients of the TCGA cohort.
| Variables | Univariate analysis | Multivariate analysis | Hazard ratio | 95% CI | value | Hazard ratio | 95% CI | value |
| Gender (male vs. female) | 0.82 | 0.57-1.16 | 0.26 | | | | Age (>60 vs. ≤60) | 1.25 | 0.88-1.77 | 0.21 | | | | Cirrhosis (yes vs. no) | 0.83 | 0.48-1.42 | 0.49 | | | | Histologic grade (G3+G4 vs. G1+G2) | 1.12 | 0.78-1.61 | 0.54 | | | | TNM stage (III+IV vs. I+II) | 2.43 | 1.69-3.55 | 0.000 | 2.38 | 1.64-3.46 | 0.000 | C2 (high vs. low) | 0.66 | 0.47-0.93 | 0.02 | 0.68 | 0.47-0.99 | 0.04 |
|
|